Koyfin Home > Directory > Health Care > Kezar Life Sciences Inc > Net Debt / EBITDA

Kezar Life Sciences Inc Net Debt / EBITDA Chart (KZR)

Kezar Life Sciences Inc annual/quarterly Net Debt / EBITDA from 2017 to 2020. Net Debt / EBITDA is a measure of leverage for a company by dividing the Debt less Cash on hand vs. EBITDA.
  • Kezar Life Sciences Inc Net Debt / EBITDA for the quarter ending June 06, 2020 was $4m a 46.90% increase of 2m year over year
  • Kezar Life Sciences Inc Net Debt / EBITDA for the last 12 months ending June 06, 2020 was $4m a 37.95% increase of 2m year over year
  • Kezar Life Sciences Inc Annual Net Debt / EBITDA for 2019 was $2m a -114.25% decrease of -2m from 2018
  • Kezar Life Sciences Inc Annual Net Debt / EBITDA for 2018 was $4m a -33.17% decrease of -1m from 2017
  • Kezar Life Sciences Inc Annual Net Debt / EBITDA for 2017 was $6m a 81.47% increase of 5m from 2016
Other Ratios Metrics:
  • Kezar Life Sciences Inc Other Liabilities for the quarter ending September 09, 2018 was $3m
View Chart On Koyfin

Quarterly KZR Net Debt / EBITDA Data

06/2020$4m
03/2020$3m
12/2019$2m
09/2019$2m
06/2019$3m
03/2019$3m
12/2018$4m
09/2018$5m
06/2018$4m
03/2018$2m

Annual KZR Net Debt / EBITDA Data

2019$2m
2018$4m
2017$6m
2016$1m